logo

For the Inventor, By the Inventor

Glenn Rock, NJ, United States of America

Cortex Pharmaceuticals, Inc.


USPTO Granted Patents = 15



Trademarks = 1

Forward Citations = 207

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Rudolf Mueller (8 out of 11 patents)

silverMedal Leslie Street (7 out of 9 patents)

bronzeMedal Gary A Rogers (5 out of 16 patents)

4.  Steven Lee (3 out of 3 patents)

5.  Christopher M Marrs (2 out of 5 patents)

6.  Gary S Lynch (2 out of 23 patents)

7.  David D Eveleth (2 out of 2 patents)

8.  Judith A Kelleher (2 out of 2 patents)

9.  Carl W Cotman (1 out of 10 patents)

10.  Clayton Harris (1 out of 24 patents)

11.  Matthew Allan (1 out of 1 patent)

12.  Jianjie Huang (1 out of 1 patent)

13.  Stanislaw Rachwal (1 out of 1 patent)

14.  Steven A Johnson (1 out of 1 patent)

15.  David D Eveleth, Jr (1 out of 2 patents)


15 patents:

1. 8642633 - Di-substituted amides for enhancing glutamatergic synaptic responses (2014-02-04),
2. 8507482 - Bicyclic amide derivatives for enhancing glutamatergic synaptic responses (2013-08-13),
3. 8404682 - Di-substituted amides for enhancing glutamatergic synaptic responses (2013-03-26),
4. 8263591 - Bicyclic amides for enhancing glutamatergic synaptic responses (2012-09-11),
5. 8168632 - Bicyclic amide derivatives for the treatment of respiratory disorders (2012-05-01),
6. 8119632 - Bicyclic amide derivatives for enhancing glutamatergic synaptic responses (2012-02-21),
7. 8013003 - Di-substituted amides for enhancing glutamatergic synaptic responses (2011-09-06),
8. 7799913 - Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses (2010-09-21),
9. 6166008 - Treatment of schizophrenia with ampakines and neuroleptics (2000-12-26),
10. 5985871 - Benzoxazine compounds for enhancing synaptic response (1999-11-16),
11. 5736543 - Benzoxazines for enhancing synaptic response (1998-04-07),
12. 5650409 - Benzoyl piperidines/pyrrolidines for enhancing synaptic response (1997-07-22),
13. 5622981 - Use of metabotropic receptor agonists in progressive neurodegenerative (1997-04-22),
14. 5567724 - Alkaline and acid phosphatase inhibitors in treatment of neurological (1996-10-22),
15. 5444042 - Method of treatment of neurodegeneration with calpain inhibitors (1995-08-22),
Cortex Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. With a strong emphasis on research and development, Cortex is dedicated to advancing the treatment options available for patients suffering from conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#1 in Glenn Rock, NJ

#806 in New Jersey

#20,435 in US

#38,729 in the World

...
Glenn Rock, NJ, United States of America

Cortex Pharmaceuticals, Inc.

Forward Citations = 207

18 inventors:

goldMedal Rudolf Mueller (8 out of 11 patents)

silverMedal Leslie Street (7 out of 9 patents)

bronzeMedal Gary A Rogers (5 out of 16 patents)

4.  Steven Lee (3 out of 3 patents)

5.  Christopher M Marrs (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…